Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors

Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors

Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jensen, Peter, Sokilde, Birgitte, Carstensen, Elisabeth, Langer, Seppo, Creighton, Andrew, Sehested, Maxvell, Jensen, Lars
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Jensen, Peter
Sokilde, Birgitte
Carstensen, Elisabeth
Langer, Seppo
Creighton, Andrew
Sehested, Maxvell
Jensen, Lars
description Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used in combination treatments with other cytostatic agents, such as topoisomerase II poisons. The maleimide and succinimide derivatives, due to their effective topoisomerase II catalytic inhibitory activity, are also useful as extravasation agents, such as upon administration of a topoisomerase II poison.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030032625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030032625</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200300326253</originalsourceid><addsrcrecordid>eNqVi80KwkAQg3vxIOo77NWDUFr0BUSxZz0KZdyONLB_7EwLvr2L-gJCICT5sqzu18laBHgMbCgMxpPjbxo4YybFzPJZdGRkM0nhxGhMERI9ZypF1xlLSu6lsAZhxAMas6yrxZOc8Obnq2p7Pt2Ol90kiZSDSk8pOZQvYpC-qeu2qDk0-_Yf9g0uc0MT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors</title><source>USPTO Published Applications</source><creator>Jensen, Peter ; Sokilde, Birgitte ; Carstensen, Elisabeth ; Langer, Seppo ; Creighton, Andrew ; Sehested, Maxvell ; Jensen, Lars</creator><creatorcontrib>Jensen, Peter ; Sokilde, Birgitte ; Carstensen, Elisabeth ; Langer, Seppo ; Creighton, Andrew ; Sehested, Maxvell ; Jensen, Lars</creatorcontrib><description>Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used in combination treatments with other cytostatic agents, such as topoisomerase II poisons. The maleimide and succinimide derivatives, due to their effective topoisomerase II catalytic inhibitory activity, are also useful as extravasation agents, such as upon administration of a topoisomerase II poison.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030032625$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64035</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10108979$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Jensen, Peter</creatorcontrib><creatorcontrib>Sokilde, Birgitte</creatorcontrib><creatorcontrib>Carstensen, Elisabeth</creatorcontrib><creatorcontrib>Langer, Seppo</creatorcontrib><creatorcontrib>Creighton, Andrew</creatorcontrib><creatorcontrib>Sehested, Maxvell</creatorcontrib><creatorcontrib>Jensen, Lars</creatorcontrib><title>Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors</title><description>Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used in combination treatments with other cytostatic agents, such as topoisomerase II poisons. The maleimide and succinimide derivatives, due to their effective topoisomerase II catalytic inhibitory activity, are also useful as extravasation agents, such as upon administration of a topoisomerase II poison.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNqVi80KwkAQg3vxIOo77NWDUFr0BUSxZz0KZdyONLB_7EwLvr2L-gJCICT5sqzu18laBHgMbCgMxpPjbxo4YybFzPJZdGRkM0nhxGhMERI9ZypF1xlLSu6lsAZhxAMas6yrxZOc8Obnq2p7Pt2Ol90kiZSDSk8pOZQvYpC-qeu2qDk0-_Yf9g0uc0MT</recordid><startdate>20030213</startdate><enddate>20030213</enddate><creator>Jensen, Peter</creator><creator>Sokilde, Birgitte</creator><creator>Carstensen, Elisabeth</creator><creator>Langer, Seppo</creator><creator>Creighton, Andrew</creator><creator>Sehested, Maxvell</creator><creator>Jensen, Lars</creator><scope>EFI</scope></search><sort><creationdate>20030213</creationdate><title>Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors</title><author>Jensen, Peter ; Sokilde, Birgitte ; Carstensen, Elisabeth ; Langer, Seppo ; Creighton, Andrew ; Sehested, Maxvell ; Jensen, Lars</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200300326253</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Jensen, Peter</creatorcontrib><creatorcontrib>Sokilde, Birgitte</creatorcontrib><creatorcontrib>Carstensen, Elisabeth</creatorcontrib><creatorcontrib>Langer, Seppo</creatorcontrib><creatorcontrib>Creighton, Andrew</creatorcontrib><creatorcontrib>Sehested, Maxvell</creatorcontrib><creatorcontrib>Jensen, Lars</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Jensen, Peter</au><au>Sokilde, Birgitte</au><au>Carstensen, Elisabeth</au><au>Langer, Seppo</au><au>Creighton, Andrew</au><au>Sehested, Maxvell</au><au>Jensen, Lars</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors</title><date>2003-02-13</date><risdate>2003</risdate><abstract>Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used in combination treatments with other cytostatic agents, such as topoisomerase II poisons. The maleimide and succinimide derivatives, due to their effective topoisomerase II catalytic inhibitory activity, are also useful as extravasation agents, such as upon administration of a topoisomerase II poison.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_20030032625
source USPTO Published Applications
title Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A14%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Jensen,%20Peter&rft.date=2003-02-13&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030032625%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true